← Evidence map

ArticleBMC cancer2019

Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.

Junli Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

159 papers cite itlatest 60 shown

2019
…
2022
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31234823